Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Similar articles for PubMed (Select 17959658)

1.

Human astrovirus coat protein inhibits serum complement activation via C1, the first component of the classical pathway.

Bonaparte RS, Hair PS, Banthia D, Marshall DM, Cunnion KM, Krishna NK.

J Virol. 2008 Jan;82(2):817-27. Epub 2007 Oct 24.

2.

Environmental assessment reveals the presence of MLB-1 human Astrovirus in Uruguay.

Lizasoain A, Tort L, García M, Gómez MM, Leite J, Miagostovich MP, Cristina J, Colina R, Victoria M.

J Appl Microbiol. 2015 May 23. doi: 10.1111/jam.12856. [Epub ahead of print]

PMID:
26010679
3.

Wastewater Analysis Indicates that Genetically Diverse Astroviruses, Including Strains Belonging to Novel Clades MLB and VA, are Circulating Within Japanese Populations.

Hata A, Katayama H, Kitajima M, Furumai H.

Appl Environ Microbiol. 2015 May 15. pii: AEM.00563-15. [Epub ahead of print]

PMID:
25979884
4.

Type I interferon response is delayed in human astrovirus infections.

Guix S, Pérez-Bosque A, Miró L, Moretó M, Bosch A, Pintó RM.

PLoS One. 2015 Apr 2;10(4):e0123087. doi: 10.1371/journal.pone.0123087. eCollection 2015.

5.

Genetic heterogeneity and recombination in type-3 human astroviruses.

Medici MC, Tummolo F, Martella V, Banyai K, Bonerba E, Chezzi C, Arcangeletti MC, De Conto F, Calderaro A.

Infect Genet Evol. 2015 Jun;32:156-60. doi: 10.1016/j.meegid.2015.03.011. Epub 2015 Mar 14.

PMID:
25784567
6.

Environmental Assessment of Classical Human Astrovirus in Uruguay.

Lizasoain A, Tort LF, García M, Gómez MM, Cristina J, Leite JP, Miagostovich MP, Victoria M, Colina R.

Food Environ Virol. 2015 Feb 14. [Epub ahead of print]

PMID:
25680829
7.

Astrovirus VA1/HMO-C: an increasingly recognized neurotropic pathogen in immunocompromised patients.

Brown JR, Morfopoulou S, Hubb J, Emmett WA, Ip W, Shah D, Brooks T, Paine SM, Anderson G, Virasami A, Tong CY, Clark DA, Plagnol V, Jacques TS, Qasim W, Hubank M, Breuer J.

Clin Infect Dis. 2015 Mar 15;60(6):881-8. doi: 10.1093/cid/ciu940. Epub 2015 Jan 7.

8.

Environmental surveillance for human astrovirus in Shandong Province, China in 2013.

Zhou N, Lin X, Wang S, Wang H, Li W, Tao Z, Xu A.

Sci Rep. 2014 Dec 18;4:7539. doi: 10.1038/srep07539.

9.

Analysis of the ORF2 of human astroviruses reveals lineage diversification, recombination and rearrangement and provides the basis for a novel sub-classification system.

Martella V, Pinto P, Tummolo F, De Grazia S, Giammanco GM, Medici MC, Ganesh B, L'Homme Y, Farkas T, Jakab F, Bányai K.

Arch Virol. 2014 Dec;159(12):3185-96. doi: 10.1007/s00705-014-2153-9. Epub 2014 Oct 19.

PMID:
25326755
10.

Immunoglobulin flexibility in complement activation.

Feinstein A, Richardson N, Taussig MI.

Immunol Today. 1986 Jun;7(6):169-74. doi: 10.1016/0167-5699(86)90168-4.

PMID:
25290202
11.

TUNABLE COMPLEMENT ACTIVATION BY PARTICLES WITH VARIABLE SIZE AND Fc DENSITY.

Pacheco PM, LE B, White D, Sulchek T.

Nano Life. 2013 Jun;3(2):1341001.

12.

The novel complement inhibitor human CUB and Sushi multiple domains 1 (CSMD1) protein promotes factor I-mediated degradation of C4b and C3b and inhibits the membrane attack complex assembly.

Escudero-Esparza A, Kalchishkova N, Kurbasic E, Jiang WG, Blom AM.

FASEB J. 2013 Dec;27(12):5083-93. doi: 10.1096/fj.13-230706. Epub 2013 Aug 20.

13.

Crystal structure of the avian astrovirus capsid spike.

DuBois RM, Freiden P, Marvin S, Reddivari M, Heath RJ, White SW, Schultz-Cherry S.

J Virol. 2013 Jul;87(14):7853-63. doi: 10.1128/JVI.03139-12. Epub 2013 May 8.

14.

A novel peptide inhibitor of classical and lectin complement activation including ABO incompatibility.

Mauriello CT, Pallera HK, Sharp JA, Woltmann JL Jr, Qian S, Hair PS, van der Pol P, van Kooten C, Thielens NM, Lattanzio FA, Cunnion KM, Krishna NK.

Mol Immunol. 2013 Jan;53(1-2):132-9. doi: 10.1016/j.molimm.2012.07.012. Epub 2012 Aug 18.

16.

Serglycin inhibits the classical and lectin pathways of complement via its glycosaminoglycan chains: implications for multiple myeloma.

Skliris A, Happonen KE, Terpos E, Labropoulou V, Børset M, Heinegård D, Blom AM, Theocharis AD.

Eur J Immunol. 2011 Feb;41(2):437-49. doi: 10.1002/eji.201040429. Epub 2010 Dec 30.

PMID:
21268013
17.

Potent inhibition of the classical pathway of complement by a novel C1q-binding peptide derived from the human astrovirus coat protein.

Gronemus JQ, Hair PS, Crawford KB, Nyalwidhe JO, Cunnion KM, Krishna NK.

Mol Immunol. 2010 Nov-Dec;48(1-3):305-13. doi: 10.1016/j.molimm.2010.07.012. Epub 2010 Aug 21.

PMID:
20728940
18.

Molecular characterization of astrovirus infection in children with diarrhea in Beijing, 2005-2007.

Guo L, Xu X, Song J, Wang W, Wang J, Hung T.

J Med Virol. 2010 Mar;82(3):415-23. doi: 10.1002/jmv.21729.

PMID:
20087940
19.

Human astrovirus coat protein binds C1q and MBL and inhibits the classical and lectin pathways of complement activation.

Hair PS, Gronemus JQ, Crawford KB, Salvi VP, Cunnion KM, Thielens NM, Arlaud GJ, Rawal N, Krishna NK.

Mol Immunol. 2010 Jan;47(4):792-8. doi: 10.1016/j.molimm.2009.10.006. Epub 2009 Nov 6.

PMID:
19896716
20.

Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.

Halili MA, Ruiz-Gómez G, Le GT, Abbenante G, Fairlie DP.

Biochemistry. 2009 Sep 8;48(35):8466-72. doi: 10.1021/bi900679r.

PMID:
19642650
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk